Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. (scientific article published on 30 January 2013)

Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma

Q33495735

T cell co-stimulatory molecules other than CD28.

Q33664723

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

Q34093165

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Q34144779

Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice

Q34445583

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses

Q34778834

Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression

Q34831296

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells

Q34987934

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

Q35081453

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice

Q35187089

B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastoma.

Q35444346

Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice.

Q35484992

Derangement of immune responses by myeloid suppressor cells

Q35573513

Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation

Q35657838

Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses

Q35849720

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

Q36371632

CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors

Q36488901

Maintenance of the plasma cell pool is independent of memory B cells

Q36534521

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

Q36693339

Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Q37346143

4-1BB signaling beyond T cells

Q37728213

B-cell targeted therapies in human autoimmune diseases: an updated perspective

Q37781401

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

Q38345478

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

Q40338318

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

Q40440899

Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor

Q40683067

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Q43966225

B cells turn off virgin but not memory T cells

Q44039722

Inhibitory effects of B cells on antitumor immunity.

Q44423014

Induction of CD4+ T-cell anergy and apoptosis by activated human B cells

Q44445127

B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma.

Q44945891

Exacerbation of ulcerative colitis after rituximab salvage therapy

Q45226801

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

Q46068963

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

Q46508260

Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma

Q47324803

Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors.

Q51790153

Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

Q53200046

NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma.

Q53257187

B cells inhibit induction of T cell-dependent tumor immunity.

Q53682449

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

Q56904469

Natural resistance mechanisms may play a role in protection against chemical carcinogenesis

Q72121067

CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells

Q72222855

Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation

Q77704355

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease

Q79787098

Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner

Q79912617

Development of psoriasis after B cell depletion with rituximab

Q80707086

B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity

Q81452723

Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma

Q81461493

B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit

Q82807525

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

2127-2138

P577

publication date

2013-01-30

P1433

published in

Cancer Research

Q326097

P1476

title

Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L

P478

volume

Reverse relations

cites work (P2860)

Q92864490	A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity
Q34106843	Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity
Q36767874	Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers
Q28551184	Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells
Q90506533	B cell and B cell-related pathways for novel cancer treatments
Q39381508	B cell regulation in cancer and anti-tumor immunity.
Q38167668	B cell regulation of anti-tumor immune response
Q26738867	B cell regulation of the anti-tumor response and role in carcinogenesis
Q42553558	B cells for cancer immunotherapy
Q92978709	B cells, plasma cells and antibody repertoires in the tumour microenvironment
Q44779139	B lymphocytes and cancer: a love-hate relationship
Q39720114	CD19(+) CD20(-) CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remission
Q38170150	Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
Q34103969	Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
Q38991275	Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-RasG12V-Induced Squamous Tumors
Q90019854	Follicular cytotoxic CD8 T cells present high cytokine expression, and are more susceptible to Breg-mediated suppression in non-small cell lung cancer
Q34138195	Generation and identification of tumor-evoked regulatory B cells
Q42217642	How much sunlight is enough?
Q91317402	IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation
Q47098673	IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
Q85211594	IRF5: a rheostat for tumor-infiltrating lymphocyte trafficking in breast cancer?
Q89556686	Immune crosstalk in cancer progression and metastatic spread: a complex conversation
Q36021465	Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.
Q40167058	Increased B Regulatory Phenotype in Non-Metastatic Lymph Nodes of Node-Positive Breast Cancer Patients.
Q64929428	Influence of Resveratrol on the Immune Response.
Q37227553	Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.
Q53327428	Introduction: Regulatory B Cell Special Issue-making all the pieces fit.
Q90468071	Levels of regulatory T cells and invariant natural killer cells and their associations with regulatory B cells in patients with non-Hodgkin lymphoma
Q38201655	Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?
Q39109245	Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune Diseases
Q93052035	Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
Q94599625	Omics-wide quantitative B-cell infiltration analyses identify GPR18 for human cancer prognosis with superiority over CD20
Q37352695	PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.
Q39084950	Potential importance of B cells in aging and aging-associated neurodegenerative diseases
Q36093770	T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis
Q64921356	The B-side of Cancer Immunity: The Underrated Tune.
Q92417123	The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer
Q33765986	The roles of regulatory B cells in cancer
Q90423337	Tumor-Derived Thymic Stromal Lymphopoietin Expands Bone Marrow B-cell Precursors in Circulation to Support Metastasis
Q52328709	Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer.
Q37616487	Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.
Q36629387	Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.

P356	DOI	10.1158/0008-5472.CAN-12-4184
P932	PMC publication ID	3618504
P698	PubMed publication ID	23365136